Hapbee’s (HAPB) Sleep Aid Lands on the Shelves of Target When we first came across Hapbee (HAPB) we described it as having a medical technology (a device) that had the “highest potential over any we follow.” Big claim of course, and we believe that to this day.
While the inventor of the technology (Emulate Therapeutics) has to undergo the rigorous and costly FDA approval process, Hapbee does not. The reason is instead of positioning the technology as a medical device, they smartly positioned it as a consumer health and wellness market device.
Read more https://internetstockreview.com/hapbees-hapb-revolutionary-sleep-aid-lands-on-shelves-of-target/